Over 40 new jobs will be created at Pfizer’s manufacturing sites in Cork, Ireland, including at a bulk Lipitor facility once earmarked for closure.
The MHRA has signed a Memorandum of Understanding (MOU) with Indian regulators to help ensure the quality of drugs in the UK.
Buying an API plant from its supplier Acacia Lifesciences proved more advantageous than building a new facility, says Indian drugmaker Biocon.
BASF expects to reduce its workforce though natural employee turnover rather than redundancies as part of a new €1bn cost cutting plan.
A second Sandoz biosimilar has been accepted for review by US FDA setting the stage for another potential legal battle with Amgen.